Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Califf

Showing results (331-340 of 567) with videos related to

Pageof 57
Sort By:
Coronary Artery Disease|February 1, 1993
Safety and antiplatelet effect of murine monoclonal antibody 7E3 Fab directed against platelet glycoprotein IIb/IIIa in patients undergoing elective coronary angioplastyS G Ellis, J E Tcheng, F I Navetta, et al.
Lancet (London, England)|April 9, 1994
Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC InvestigatorsE J Topol, R M Califf, H F Weisman, et al.
Circulation|April 15, 1995
One-year follow-up in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT I)J M Elliott, L G Berdan, D R Holmes, et al.
Circulation|January 15, 1995
Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarctionC L Grines, E J Topol, W W O'Neill, et al.
Circulation|June 3, 1997
Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The Global Utilization of Streptokinase and Tissue Plasminogen activator for Occluded coronary arteries (GUSTO) I InvestigatorsS D Berkowitz, C B Granger, K S Pieper, et al.
The New England Journal of Medicine|September 29, 1991
Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery diseaseD B Mark, L Shaw, F E Harrell, et al.
Journal of the American College of Cardiology|October 1, 1996
Increased risk of non-Q wave myocardial infarction after directional atherectomy is platelet dependent: evidence from the EPIC trial. Evaluation of c7E3 for the Prevention of Ischemic ComplicationsJ Lefkovits, J C Blankenship, K M Anderson, et al.
Circulation|November 16, 1999
Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevationD R Holmes, P B Berger, J S Hochman, et al.
The American Journal of Medicine|September 1, 1988
Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarctionR M Califf, E J Topol, B S George, et al.
Journal of the American College of Cardiology|November 15, 1997
Comparative prognostic significance of simultaneous versus independent resolution of ST segment depression relative to ST segment elevation during acute myocardial infarctionA Shah, G S Wagner, R M Califf, et al.
Pageof 57

Showing results (331-340 of 567) with videos related to

Sort By:
Pageof 57
Coronary Artery Disease|February 1, 1993
Safety and antiplatelet effect of murine monoclonal antibody 7E3 Fab directed against platelet glycoprotein IIb/IIIa in patients undergoing elective coronary angioplastyS G Ellis, J E Tcheng, F I Navetta, et al.
Lancet (London, England)|April 9, 1994
Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC InvestigatorsE J Topol, R M Califf, H F Weisman, et al.
Circulation|April 15, 1995
One-year follow-up in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT I)J M Elliott, L G Berdan, D R Holmes, et al.
Circulation|January 15, 1995
Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarctionC L Grines, E J Topol, W W O'Neill, et al.
Circulation|June 3, 1997
Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The Global Utilization of Streptokinase and Tissue Plasminogen activator for Occluded coronary arteries (GUSTO) I InvestigatorsS D Berkowitz, C B Granger, K S Pieper, et al.
The New England Journal of Medicine|September 29, 1991
Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery diseaseD B Mark, L Shaw, F E Harrell, et al.
Journal of the American College of Cardiology|October 1, 1996
Increased risk of non-Q wave myocardial infarction after directional atherectomy is platelet dependent: evidence from the EPIC trial. Evaluation of c7E3 for the Prevention of Ischemic ComplicationsJ Lefkovits, J C Blankenship, K M Anderson, et al.
Circulation|November 16, 1999
Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevationD R Holmes, P B Berger, J S Hochman, et al.
The American Journal of Medicine|September 1, 1988
Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarctionR M Califf, E J Topol, B S George, et al.
Journal of the American College of Cardiology|November 15, 1997
Comparative prognostic significance of simultaneous versus independent resolution of ST segment depression relative to ST segment elevation during acute myocardial infarctionA Shah, G S Wagner, R M Califf, et al.
Pageof 57